PubMed İndeksli Yayınlar Koleksiyonu

Permanent URI for this collectionhttps://hdl.handle.net/20.500.12573/397

Browse

Search Results

Now showing 1 - 2 of 2
  • Article
    Performance Boost in QLEDs Using Octanethiol-Capped Core/Shell Quantum Dots
    (IOP Publishing Ltd, 2026-01-07) Yazici, Ahmet F.; Yuruc, Adnan M.; Kelestemur, Yusuf; Serin, Ramis Berkay; Kacar, Rifat; Ulku, Alper; Mutlugun, Evren
    Quantum dots attract significant attention as one of the most promising colloidal nanocrystals with unique optical properties and potential applications for the next generation of display technology. In this paper, we evaluate the performance of CdZnSeS-based alloyed-shell quantum dots (QDs) for electroluminescence devices upon additional shell growth and ligand exchange. This includes core/shell (C/S) and core/shell/shell (C/S/S) QDs, whose latter includes an additional ZnS shell and octanethiol (OT) ligands. We present detailed characterizations of QDs using transmission electron microscopy, XRD, and various spectroscopic techniques and demonstrate their QD light emitting (QLEDs). We find the photoluminescence quantum yield of C/S/S QDs increased from 68.8% to 88.7% compared to C/S QDs whereas the emission linewidth narrows from 22.2 nm to 20.8 nm. QLEDs fabricated with C/S/S QDs exhibit a higher peak external quantum efficiency (EQE) of 4.1% and maximum luminance of 85 000 cd m-2, compared to 2.3% EQE and 67 000 cd m-2 for C/S QLEDs. In this respect, the OT-assisted shell growth significantly improves the optical property of QDs and performance of QLEDs, likely attributed to the enhanced charge balance and increased radiative recombination rate.
  • Article
    A Potential Hemostatic Chitosan/Gelatin Cryogel Impregnated with Verbascum Thapsus Leaf Extract for Noncompressible Hemorrhage Management
    (IOP Publishing Ltd, 2025-11-01) Uzuner, Hacernur; Yuruk, Adile; Isoglu, Ismail Alper
    In this study, we prepared a series of chitosan/gelatin (CS/GEL) cryogels containing Verbascum thapsus (V. thapsus) leaf extract and identified a lead formulation for noncompressible hemorrhage (NCH). Cryogels with average pore diameters ranging from 225 to 478 mu m were fabricated through cryogelation at various CS/GEL ratios. C15 was chosen as the base scaffold due to its homogeneous pore distribution, with a pore size coefficient of variation (CV) of approximately 0.22. Extract loading was 1%, 5%, 10%, and 20% w/v. Functional porosity was reported by the relative accessible void index (RAVI). In PBS, the values relative to neat C15 were 1.00, 0.27, 0.20, 0.13, and 0.09 for concentrations of 0%, 1%, 5%, 10%, and 20% w/v, respectively. In citrated blood, the series was 1.00, 0.29, 0.12, 0.14, and 0.09. After loading, equilibrium swelling decreased and the compressive modulus increased, consistent with partial pore filling in a fixed network. The cryogels maintained an interconnected macroporous network and showed swelling from 300% to 3600% in blood and PBS. Antibacterial activity reached 89% inhibition, and cell viability remained above 80%. Hemolysis was low and within acceptance limits. Clotting improved in whole blood as the blood clotting index decreased from 11.9 to 6.5, and the clotting time was approximately 6 min. The 5% w/v group provided the optimal balance of clotting, antibacterial effects, and biocompatibility. This study presents a novel hemostatic CS/GEL cryogel containing V. thapsus leaf extract that holds strong potential for future applications in NCH management.